Menu

Dublin to host 12th European Pain Federation Congress

Dublin will host the 12th European Pain Federation Congress (EFIC) in 2021 at The Convention Centre Dublin (The CCD).

The congress will bring together 3,000 multidisciplinary clinicians and researchers from the fields of pain science at the event, which is estimated to generate more than £3.7 million for the local economy.

Adrienne Clarke, head of conference sales at The CCD said: “We are looking forward to welcoming EFIC to Dublin after working closely with IPS, DCB and Fáilte Ireland.

“With over 75 pharmaceutical companies operating in Ireland, including the top ten in the world, Dublin is a great fit for this type of congress.”

Ireland has a long history in pain management research with the first injection administered for pain relief invented by Dublin doctor, Francis Rynd in 1844.

The successful bid was presented to EFIC’s executive board in Brussels by Joanne O’Brien, president of the Irish Pain Society (IPS).

The bid focussed on teamwork with support from Dublin Convention Bureau (DCB), Fáilte Ireland and The CCD, along with letters of support from both the lord mayor of Dublin and Minister for Health, Simon Harris.

“The Irish Pain Society is honoured to welcome the 12th EFIC to the vibrant city of Dublin, home of doctor Francis Rynd, inventor of the first hypodermic needle, a game-changer in modern pain management,” said O’Brien.

“We are delighted that our own UCD associate professor, Brona Fullen will be president of EFIC at this time, and together with the scientific chair, professor Eija Kalso will bring together the world’s leading experts to exchange knowledge, ideas and the latest advances in the field of pain science.”

The 12th European Pain Federation Congress will be the largest scientific congress on pain in 2021. The programme will include plenary lectures, workshops, refresher courses and networking initiatives on almost every aspect of pain. The congress will cover acute, chronic, cancer and non-cancer pain and will include the newest developments in basic science and care for patients suffering from pain.